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Recollections of My Research in 
Developing the 
Heart-Lung Machine 
at Jefferson Medical College 
[typescript, 24 pages] 
l. 
Thomas Jefferson University Archives .& 
Special Collections 
Manuscript # 113 
l~-cf1~ 
Dr. Bernard J. Miller, M.D. 
... .. 
My initial interest and fascinatic>n with research began while I was attending high school. 
Following graduation, I succeeded in obtaining a volunteer position in the laboratory of the 
Cancer Research Institute of Lankenau Hospital, which is now the Fox Chase Cancer Research 
Institute of Philadelphia. During vacation periods while at college, I would work in the 
laboratory on a foll time basis and, during the winter, I would manage to work 1~2 evenings a 
week and, in addition, the entire weekend. My initial assignments consisted in cleaning the urine 
specimen bottles and then I very quickly advanced to the pathology laboratory, learning to 
prepare specimen slides, and then to doing experimental embryology, under the direction of Dr. 
Stanley P. Reimann, the Director of the institute. I was involved in the recovery of human ova 
from operative s;iecimens, mitotic manipulation of the human ova, and, eventually, the use of 
fertilized rabbit ova in circulating tissue culture as a method for studying the affects on growth of 
various amino acids. There were a number of publications and presentations that I made during 
' 
that period: The fiiendship with Dr. Reimann continued on a father/son basis for many years 
thereafter until his death. At graduation from Villanova College, I was first in my class. 
Following my gtllduation from Jefferson in 1943 and having achieved the Dean's List, the Honor 
Society AOA, and recipient of the Medal in Surgery at graduation, I was offered the internship at 
Jefferson, which had been reducecl to a nine month period at that time because of the need for 
medical officers in the armed services during World War II. I completed my internship and was 
then retained for an additional two nine month periods as a resident in general surgery, un;ier Dr. 
George P. Muller. My work during my residency at Jefferson and prior to entering the armed 
services was exernplary, and I had hoped to return to Jefferson at the conclusion of my tour of 
duty in the armed services, to complete my surgical training. 
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As my tour of duty was coming to an end, I request~d an appointment with Dr. Gibbon. who had 
been appointed as the Professor of Surgery and Chief of the Surgical Services following Dr. 
Muller's death, for the purpose of discussing the resumption of my residency training after 
separation from the armed services. I came to Philadelphia to meet with Dr. Gibbon and, as I 
recall, I was immediately told that there was no longer any place for me in the surgical residency 
training program at Jefferson nor would there :be in the future. I was truly amazed, first since my 
perfonnance in the early part of my residency at Jefferson had been exemplary, and it was my 
impression that r~tuming veterans would be welcomed to the positions they had occupied prior 
to entering the service. I knew of no reason for Dr. Gibbon's feelings, although I did have some 
personal thoughts about that. 
Influential friends and admirers of my work at both The Lankenau Research Institute and 
Jefferson became aware of this. They immediately contacted the dean of Jefferson Medical 
College and Mr. Rosenwald, Chairman of the Board at Sears, Roebuck and also a member of the 
Board of Trustees at Jefferson Medical College. Within a few days following my interview with 
Mr. Rosenwald, D.r. Gibbon wrote to me at Fort Bragg informing me that I would be able to 
continue my surgical training at Jefferson following honorable discharge from the service. 
In July of 1947, I was separated from the Army with honorable discharge and returned to 
Jefferson to meet with Dr. Gibbon. He informed me that there was no place available in rhe 
hospital for me s.t that time and that I would need to spend a year in the surgical research 
laboratory prior to clinical experience. His attitude was one of complete indifference. He did, 
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however, suggest that I interest myself in the problem of blood volume changes in surgical 
patients undergoing major thoracic operations in which he was interested. and he directed me to 
the laboratory where "I could find some test tubes and some blue dye T ~ 1824." This was 
completely satisfactory to me since I was eager to return to Jefferson for continuation of my 
surgical lraining in any manner. 
I started the new research project very energetically and, within a short time, was making 
measurements of blood volumes before and after major thoracic operations and correlating this 
with changes in the extracellular fluid space and then relating this study to a parallel study where 
actual intraoperative blood loss was determined by the weighing of sponges used during the 
operations. By Thanksgiving of 1947, I had accumulated a significant amount of data and,Jor 
the first time, requested an interview with Dr. Gibbon for the purpose of discussing the findings 
of the blood volume study. I met with hlm and Frank Allbritton, and they reviewed my work 
very critically. They were very impressed with my findings, remarking to each other "Gee 
Frank, have we done all this damn work." They then directed me to write a paper and submit it 
to the American Thoracic Association for presentation at the spring meeting in Quebec, Canada. 
This paper was well received. The photo that was taken of Allbritton, Templeton, and me at the 
Frontenac was actually made during that meeting. Following the presentation of the paper, both 
Gibbon and Allbritton's attitude changed appreciably, and they actually became cordial. In fact, 
by Christmas of that year, Dr. Gibbon invited Ethel, my wife, and me to a reception at his home. 
He met us at the door and, with his ru.ms around both of us, directed us to his study, at which 
time he said, "BJ; let bygones be bygones." Ethel and I were absolutely amazed. 
\ 
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From that time on, work in the laboratory became extremely enjoyable, pleasant, and also 
progressed very rapidly. I extended the work to blood volume measurements in patients with 
tuberculosis during stages of thoracoplasty and developed a method of objective measuring the 
circulation time by detecting the moment of arrival of intravenously injected blue dye at the lobe 
of the ear with an oximeter which I had designed and constructed. The study was further 
extended to correlating dye dilution patterns in the blood of the ear lobe as detected by the 
recording oxime'ter with various levels of cardiac shunts. I did not publish this work because 
there were only a few such cases available at that time. There was, however, a very definite 
dilution pattern specifically for each level of intracardiac shunt. In July of 1948, I was 
transferred into the hospital to complete the clinical aspects of my surgical residency and spent 
the next 2 Y2 years in intense surgical training. I thoroughly enjoyed this time and developed a 
fondness·and res·pect for Dr. Gibbon. 
At the end of the surgical residency, Dr. Gibbon effered me the position of research assistant on 
a full time basis. ·I could not accept this on the basis of full time because we were having our 
first child and, during my surgical residency at Jefferson, I did not receive any financial support 
from the hospital ·so I needed to get on with making a few dollars. He did, however, change his 
offer, offering me the same salary, namely $3,600 a year, on a part time basis. ·within a few 
months, after my position as research assistant began, he increased my salary to $4,800 a year on 
a part time basis· and appointed me research associate. I had the opportunity of developing a 
small surgical practice of my own by that time which I managed in the afternoon and evening. 
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Following World War II, Mr. Thomas J. Watson, Chainnan of the Board of the International 
Business Machine Corporation, became interested in helping Gibbon develop a heart/lung 
machine, and he assigned the experimental laboratory at Binghampton, New York to the 
.. 
construction of such a machine. Don Rex was the engineer appointed for the project. In 1947, 
the first of the ffiM heart/lung machines arrived and was used extensively in animal 
experimentation by Stokes and Flick. h1 essence, the machine was a duplicate of the original 
machine used by Gibbon in his 1937 and 1938 experiments and actually similar to that originally 
patented in 1922 by Pierre DeLosolot in France. The only difference between the new IBM 
machine and the device used by Gibbon originally was that it had a much larger smooth film 
type oxygenator and the collecting bowl at the bottom of the oxygenator was gold plated with the 
thought that there would be less interaction between gold and stainless steel by the blood. 
After an extensive animal experience, the machine appeared to be completely inadequate for 
human perfusion. There were a number of defects in the performance of the device. 1. The 
oxygenator was completely inadequate and could not support the respiratory requirement of even 
a large dog. The control of the arterial pump was photoelectric and malfunctioned frequently 
resulting in air embolization of the subject being perfused. The machine occupied two stainless 
steel and glass cabinets and was beautifully machined. To have enlarged a smooth film 
oxygenator such as this to the point where it would have had sufficient capacity to t\Xygenate a 
large dog or a very small human would require a geometric design of unrealistic prop~;rtion and 
also blood hold up. 2. There was, in addition, a large amount of hemolysis. 3. As the wcrk 
progressed, it became evident very quickly that the matter of respiratory acidosis developing 
during the thoracotomy and perfusion needed to be corrected. Other problems also needed 
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solution, namely the continuous removal, without loss, of a large volume of cardiac venous 
blood returning to the right atrium during open atriotomy and removal of foam within the left 
ventricle at the time an interventricular or interatrial septal defect existed when atmospheric air 
entered the left side of the heart by way of the defect. At this point in time, it was clearly 
obvious that another machine needed to be built based hopefully on the solution of the problems 
which I have outlined. Mr. Watson assigned three engineers, AlfMalmros, senior engineer, John 
Engstrom, and Leo Farr, to the project concerned with the construction of a new machine. 
Animal experiments were suspended. 
Richard and Drirlker many years before introduced the element of turbulence in a smooth film 
oxygenator by forming the blood film on a silk screen and demonstrated that the degree of 
oxygenation could be vastly increased. Accordingly, Stokes and Flick lined the existing cylinder 
with a stainless steel screen and were able to show a significant improvement in oxygenation. At 
this point, all animal experiments were terminated. It was decided to use the existing machine as 
a supporting structure for furthe:r testing of new and advanced components. 
The laboratory staff consisted of six technical assistants who maintained and prepared the 
machine, tended to the experimental animals, and procuring and typing of donor blood. In 
addition, two surgical residents or fellows were usually assigned for a nine month period to the 
research laboratory. This was a superb learning experience for the residents. Many of the 
residents of that period achieved high positions in surgery here and abroad; for example, 
Anthony Dobell, in Canada, and Dr. Hans Engle, in Denmark. 
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I directed the work in the laboratory, perfonned all of the perfusion experiments, and did the 
experimental design and development of the various components that would eventually be 
incorporated into the new machine. The engineers and I constantly communicated by phone 
with each other. They would come to the laboratory when I had designed a new component for 
demonstration. This usually occurred twice monthly. In 1952, engineer Engstrom, of IBM, gave 
a paper entitled "Electronic Control Circuits of the Mechanical Heart/LW1g Apparatus" to the 
Industrial Electronic Group of the Society of Mechanical Engineers and acknowledged that I had 
conceived and tested the new control circuit. In the 1990's, I received the Holley Medal from 
the American Society of Mechanical Engineers for the fluid control servo system that I had 
designed. The system that I developed made the machine completely automatic and provided a 
safeguard against embolization and, in addition, maintained constant blood volume hold up. 
On one or two occasions, Dr. Gibbon and I went to Binghampton, New York to observe the 
progress on the construction of the new machine. Dr. Gibbon rarely came to the laboratory, only 
when prominent guests, such as Crafoord, Dennis, Byork, etc., came to the laboratory to visit and 
discuss the problems of the heart/lung machine. This fact was noted in the Gibbon lecture 
which Dr. Dobell had given at the American College of Surgeons in the 90's. Subsequently, as 
the experiments proceeded, additional problems became evident, namely that of acidosis during 
the thoracotomy and perfusion, the recovery of cardiac venous blood without loss, and the 
recovery of blood a11d foam originating in the contracting left ventricle. At this place in time, the 
heart continued to pulsate during perfusion and the repair of experimentally produced septal 
defects. 
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The first priority was to develop an oxygenator capable of supporting the cardiorespirator/ 
function of a large dog. A small test oxygenator was constructed using 2 x 12 inch strips of 
stainless steel screens of different wire sizes, mesh sizes, and punch metals suspended from a 
weir of 0.015 inches in width. This test device was then suspended in a cylinder containing 
oxygen. The oxygenation characteristic of each surface was detennined as reduced cow blood 
flowed down each surface. Data derived from these experiments provided the basis of a new 
oxygenator using a turbulent film. 
The first configuration consisted of a screen cylinder with a super-imposed cone upon which 
blood was deposited from a rotating jet. Filming of the blood was not uniform, and the blood 
tended to descend on the screen surface in rivulets producing a thick film of small surface area. 
Only after painting the screen with a protein solution, such as a dilute suspension of blood, could 
a complete film be established. The final design of the oxygenator consisted of six stainless steel 
screens, measuring 30.5 x 45 centimeters in size, suspended from individual weirs or a series of 
slots, each measuring 0.015 inches in width, and the entire assembly contained within a plastic 
case. This configuration was suggested by Alf Malmros and presented a 1.64 square meter 
surface area for oxygenation. 
It was expected that blood pumped through the weir, which was located in the floor of the 
distribution chamber at the top of each screen, would be uniformly distributed along the entire 
width of the screen. Again, filming was incomplete and erratic. A uniform film of blood could 
be established only by flooding the oxygenator case with saline solution and then, as blood was 
being pumped into the distribution chamber, the mixture of saline solution and blood was rapidly 
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emptied. The falling layer of blood located at the top of the saline solution painted the screen, 
and the film was: then maintained by the continuous recirculation of blood from the bottom of the 
oxygenator case to the distribution chamber. To reduce the volume of blood contained within 
the oxygenator assembly, the pool at the bottom was replaced, in part, by a block of plastic 
material that also served to maintain the position of the screen. The rate of flow through the 
recirculating pump was maintained at the maximwn rate for which the oxygenator was designed. 
With six screens, this oxygenator could raise the saturation of blood with oxygen from 65% to 
95% at a flow rate of 250 milliliters per minute. 
The original photoelectric level control device used for controlling the rate of evacuation of the 
oxygenator by the arterial pump functioned erratically with resulting fatal air embolism. Proper 
control of this pump was extremely critical lest air be pumped into the arterial tree of the subject 
being perfused. A new device was conceived, the blood level in the bottom of the oxygenator 
was considered one element of a capacitor. The other element of the capacitor was a fixed 
electrode separated by a dielectric which, in this case, was the plastic case of the oxygenator. 
Accordingly, a small metal electrode was incorporated within the case and completely sealed at 
the control point at which the blood level was to be maintained. The capacity between the blood 
level and the fixed plate, in conjunction with an inductance, formed a tuned circuit operating at 
10. 7 megacycles. Changes in the blood level altered the frequ~ncy of the tuned circuit and 
provided the error signal for the control of the arterial pump. The arterial pump was then 
completely controlled by the blood level in the bottom of the oxygenator case. The variable 
capacitor circuit functioned well and appeared to be completely reliable providing proportional 
control of the arterial pump at a maximum flow within 0.1 % and guarded against air 
9 
embolization of the systemic arteries. The accurate and instantaneous control of the capacitor 
system maintained the blood volume in both machine and subject at a constant level. 
A filter of new design based on the reverse flow of blood was then included in the arterial line. 
This filter provided for the removal of air or fibrin from the chamber during the initial filling if 
required. Nichrome wires were embedded in the plastic case and heated electrically only 
sufficiently to prevent condensation on the interior of the oxygenator case. 
With this modified machine, a number of dogs were successfully perfused during total bypass. 
At this time, the venous pumps were placed at a higher level than the heart of the subject being 
perfused. It was· necessary to withdraw the blood from the vena cava with a moderate degree of 
suction. Since the venous DeBakey pumps were pulsatile, the moment the rotating roller 
contacted with the rubber tube, there was a marked increase in velocity of blood flow with a 
concurrent decrease in the lateral pressure and, therefore, -'<~ u~f'lf:: tfie. caval walls 
would be drawn into the orifice of the cannula at low flow rates and interrupting vena caval 
blood flow. When this occurred, blood could not be withdraw~ through the occluded cannula 
despite the fact that the venous blood continued to flow into the cava. In order to control this, a 
small segment of thin wall collapsible rubber tubing was placed within the venous line and used 
as a pressure sensor. In the final design, a linear variable differential transformer sensed the 
intermittent collapse or change in diameter of the rubber tube in the venous circuit. A spring 
loaded lever rested against this segment of rubber tubing and was linked to the core of a different i' t11 I 
transform.er. Minute changes in the diameter of the tube as a result of variations in pressure 
during the pumping cycle produced the necessary control signal to affect reliable automatic 
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control. At the moment of occlusfon of the cava, the rubber tubing collapse was sensed by the 
device and the venous pump motors were stopped instantaneously. Intermittent erratic pressure 
changes preceding complete occlusion were indicated by fluctuation of a meter, known as a 
"flutter meter." By watching the oscillations of the flutter meter, the perfusionist was then 
alerted to reduce the speed of the venous pump and so prevent repeat occlusion of the ~ena cava 
and a cessation of blood flow into the system. 
At this point, the new machine arrived in the laboratory, and an intense program of animal 
experimentation was undertaken. The motors of the venous pump in the first IBM machine were 
direct current motors operating directly from rectifiers. The low torque at reduced speed of 
direct current motors made them unsuited for this purpose. Accordingly, in the new machine, the 
alternating current motors replaced the direct current motors of the venous pumps with the 
exception of the arterial pump motor. Variable speed control was affected by Graham 
mechanical transmissions. Quick braking of alternating current motors was achieved by 
instantaneously applying a direct current to the motor. 
The early phases of animal experimentation with the new machine took place early in 1951 .. 
Experiments with the new machine were only moderately successful. The morality was unduly 
high despite the apparent satisfactory condition of the animals during perfusion. Attention was 
now focused on this problem. Gasometric studies during anesthesia with a laboratory respirator 
revealed marked hypoxia and acidosis, probably the result of inadequate tidal exchange. 
Increasing respiratory rate or volWl1e was ineffective. The notion of assisting expiration by 
increasing tidal volume of expired gas at the expense of the reserve gas volume without 
11 
increasing intratracheal pressure by the use of suction was investigated. Additionally, by rapidly 
reducing intratracheal pressure, alveolar capillary blood pressure and tissue perfusion have been 
shown to be markedly enhanced. Accordingly, a laboratory model of a respirator containing a 
timing circuit that alternately controlled electrically operated solenoid valves on both the 
inspiratory and the expiratory lines was constructed. Expiration was assisted by suction 
produced with a Venturi jet operating from the same air pressure source. The respirator operated 
at 5-pound line pressure of compressed room air. The frequency of respiration was controlled by 
a multi vibrator circuit, which contained provisions for not only altering the rate of respiration but 
also changing the ratio of inspiration and expiration. Using room air during anesthesia with 
Pentothal and the new respirator, the saturation of blood with oxygen was 100%, and the carbon 
dioxide levels had fallen to extremely low values producing apnea after extubation of at least two 
minutes. Accordingly then, this device was used in all subsequent perfusions in the animals and 
also in the second total bypa8s in a child at Gibbon's request. At this point, the survival rate of 
perfused animals rose precipitously. 
In the latter part of 1950, I demonstrated to both Dr. Gibbon and to Dr. Allbritton the respirator 
which I had conceived and constructed. They were both very impressed by the performance of 
the respirator and the gasometric studies which I had performed. Very shortly after the initial 
demonstration, Dr. Gibbon asked me to demonstrate the device to his brother, Sam Gibbon, who 
was the owner of the Air Shields Corporation, in Warminster, Pennsylvania. His company 
manufactured incubators for premature infants and a number of other devices for the medical 
profession. Sam Gibbon came to the laboratory to see the demonstration and then invited me to 
visit his factory. Within a few days, I did visit him at his request at his factory one Sunday. He 
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showed me the facilities that were: available there. He seemed to be extremely interested in 
continuing his interest in the respirator and suggested a future meeting. Following this, I did not 
have any further contact or communication with Sam Gibbon. There was likewise no further 
discussion in the laboratory concerning the respirator. At this point in time, I did not report the 
respirator in the literature. I did state, however, very clearly, in a paper published in 1952, 
entitled "The Repair of Intra-Atrial Septa! Defects" that all animals were anesthetized with a 
positive negative pressure respirator. 
The entrance to Allbritton's office was directly opposite the entrance to the experimental 
laboratory where the respirator was in constant use with perfusion experiments. Within a few 
months, I became aware of the fact that George Haupt, a resident at that time assigned to 
Allbritton, were in the process of further investigating expiratory assistance with a mechanical 
version of the respirator using negative pressure. At this point, the door to Allbritton's office, 
which was directly opposite, was always kept closed. As I look back, the reason being, of 
course, to secret from my view what they were doing. Following my departure from the 
Department of Surgery as research associate in 1954, I did publish an article describing the 
respirator using expiratory assistance purely as a matter of record, but this, of course, was many 
years after its original demonstration. I was no longer privy to what Allbritton and Haupt were 
doing. 
I must refer now to the book entitled "John Gibbon and His Heart/Ltmg Machine", by Ada 
Romain Davis, published in 1991, and the statement made by her at the very outset, namely, 
"Frank Allbritton, Jr., M.D. and George J. Haupt, M.D. were consultants extraordinaire who 
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helped make this book a reality." Imp01tantly, at this point in time (1992), George Haupt was 
very ill and was confined to a wheel chair at his home. Although he may have provided some 
infonnation to the author, the bulk of the information concerning the book was provided by 
Frank Allbritton. On Page 112 of the book entitled "Gibbon and His Heart/Lung Machine," 
wider the title of the Early 1950's, the information referable to the respirator which I had 
originally conceived and demonstrated is taken directly from my article. At this point, let me 
state the pertinent feature of that article. "The mortality rate of animals was widuly high despite 
the fact their condition during perfusion appeared satisfactory. After examining possible factors, 
the critical problem related to the method of anesthesia which neither provided sufficient 
oxygenation nor prevented acidosis. This was further substantiated by determination of blood 
gases in the subject during anesthesia, prior to perfusion, and also following perfusion. The 
problem was inadequate washing out of carbon dioxide and inadequate saturation of blood with 
oxygen. The concept of assisting expiration by introducing negative pressure was considered a 
possible solution. Therefore, a laboratory model of a ventilator device containing a timing 
circuit resulted which alternately operated solenoid valves both on the inspiratory and expiratory 
lines of the device was conceived by Haupt, then a resident - untrue. Expiration was assisted by 
using the Venturi jet to provide suction. Tests using this device showed that oxygenation was 
complete. It was possible to super saturate blood with oxygen using room air; a large amowit of 
carbon dioxide could then be removed from the circulating blood to the point where the animal 
would remain apneic for a number of minutes. The ventilator was :incorporated into the 
procedure and used in all subsequent animal experiments." 
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In 1954, Allbritton, senior author, and Haupt, then a resident, read a paper at the American 
Surgical Association entitled ''The Changes in Pulmonary Ventilation Achieved by Aiding the 
Deflation Phase of Respiration During Anesthesia for Surgical Operations." Incredibly, in this 
paper, there is no mention of the fact that they, including Gibbon, were aware of this 
development at least three years prior to their so called original research. On Page 71, second 
column of Allbritton's paper, one is left with the thought that expiratory assistance during 
anesthesia originated completely at this time. Unbelievably, Gibbon was the editor of the Annals 
of Surgery and highly respected at that time, and I am amazed that he approved the publication 
of such a deception. In fact, in the discussion of Allbritton's paper, Gibbon repeats the same 
description of the anatomic findings as I had originally made. Since I had left the laboratory 
about this time, I was not aware that Sam Gibbon was in the process of manufacturing and 
distributing the device which was also patented by Haupt and cannot conceive of such scientific 
dishonesty. 
In Ada Davis' book, Page 169, she indicates clearly that the two Gibbon brothers were 
frequently associated in various aspects of business as it related to the oxygenatcr and other 
I 
kinds of surgical equipment and technology. At this pointt Sam Gibbon's Air Shields 
Corporation became the sole manufacturer of the Haupt Jefferson ventilator developmentt and, 
obviously, they had many interests in common. Jefferson ventilators were distributed in. large 
numbers both here and abroad. I believe that Gibbon and Allbritton benefitted financially 
immeasurably. George Haupt assigned the royalties to Jefferson andt following the completi.:m 
of his residency, he was appointed Chief of Cardiac Surgery at the Lankenau Hospital, an 
affiliated hospital of the Jefferson network. 
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The importance of expiratory assistance as stated by Dr. Jay Jacoby, Chairman of the 
Department of Anesthesia of Thomas Jefferson University, is found in "Tradition and Heritage, 
Thomas Jefferson University." Let me quote at this point, on Page 631, "A second significant 
contribution of Jefferson surgeons through anesthesiology consisted in the development of the 
Jefferson ventilator, the patent obtained by George Haupt, was signed by Andrew Jefferson. He 
was aided in his work by Frank Allbritton and Jose Amadao, who co-investigated expiratory 
assistance as the means of improving ventilation and avoiding respiratory acidosis during 
anesthesia. Dr. Bernard J. Miller, Jefferson '43, had previously conducted the research on the 
important role of expiratory assistance during anesthesia. It was the same Dr. Miller who was 
also closely associated with Dr. Gibbon in the design of electronic and other components for the 
heart/lwig machine." Further.on, he states clearly that ''The Jefferson ventilator was the 
prototype of the thousands of!Vo1ume ventilators used throughout the world in operating rooms 
and intensive care units. Unt0ld numbers of patients owe their lives to this development." 
Following the appearance of the book and the availability of the contained information to me for 
the first time, I visited Dr. Haµpt at his home who, at that point, was wheel chair bound and 
discussed the matter of scientjfic honesty and his role in the statement contained in the book that 
involved him as the one who first conceived of and developed expiratory assistance. Haupt 
informed me that the information which was provided to the author, Davis, was given completely 
by Frank Allbritton, and he was not sure what his motive was. I have enclosed a copy ofHaupt's 
statement which says as follows: ''The statement by Ada Romain Davis in her book entitled 
"John Gibbon and His Heart/Lung Machine" describes the use of negative pressure in assisting 
16 
expiration during anesthesia and the description of the laboratory ventilator attributes the 
development to me. I was not a')sociated in any way with this work. Dr. Bernard J. Miller 
deserves all the credit for conceiving of the use of negative pressure to assist expiration during 
anesthesia and the design and the construction of the laboratory ventilator. He made the first 
laboratory tests in experimental animals with the method, and he established the usefulness of 
negative pressure for this purpose." As an addendum in Haupt's statement, he states the name 
B.J. Miller should be substituted for Haupt, then a resident, because I was not associated with the 
experiments using ventilation in conjunction with the heart/lung machine." I am including 
Haupt's signed statement. When the University of Pennsylvania Press became aware of this 
deception by Frank Allbritton, John Gibbon, and Haupt, they immediately suspended further 
publication of the book and actually verbally remarked that they regretted they had ever 
published the book. Within a few hours after the University Editorial Board became aware of 
the problem, I was contacted by Davis, who I am sure was fearful of some problem. I did not 
have any interaction with Allbritton at this time. The University of Pennsylvania then published 
an addendwn, a copy of which I have included for your infonnation, which was sent to a nwnber 
of surgical journals both in the United States and abroad. 
Since the ultimate goal of this work was to achieve a bloodless cardiac chamber during total 
bypass providing a means for the perfonnance of precise surgical operations in human patients 
under direct vision, the next logical step was to create defects within the septa and then to 
attempt repair under direct vision while the cardiorespiratory function was maintained by the 
heartJlung machine. As we had hoped, the new machine fooctioned flawlessly during totaJ 
bypass experiments with most animals surviving. The blood volumes of both the subject and the 
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machine were precisely maintained; the pH was maintained within normal range, and the 
servocontrol systems protected against air ernbolization completely and maintained constant hold 
up in the machine. Therefore, the next logical step was to create defects within the septa wtder 
direct vision during total bypass and then attempt to repair them whifo the cardiorespiratory 
function was maintained by the heart/lung machine. The magnitude of cardiac venous blood 
entering the right atrium was not fully anticipated before the first atriotomy during bypass. The 
first experiment was a failure because the large volume of blood returning to the right atriwn by 
way of the sinus and the anterior cardiac veins could not be coped without loss by simple means. 
An additional and unforeseen complication appeared when experimental atrial defects were 
produced during bypass. Air entered the left atrium as soon as the interatrial septal defect was 
produced. Blood and air trapped beneath the mitral leaflets were then pumped by the pulsating 
left ventricle into the systemic circulation, thus embolizing the coronary circulation and other 
systemic arteries. This was indeed a profound complication, but the solution was actually quite 
simple. A tube was introduced into the left ventricle of the beating heart by ventriculotomy at 
the apex in the out-flow tract and secured with a purse string suture provided a low impedance 
pathway for the escape of the air from the contracting left ventricle with the assistance of mild 
suction. At a discussion in the laboratory of the problem, Allbritton, during this, the only such 
meeting which he had ever attended, suggested decompression of the left side by way of a 
catheter in the left appendage. Both the returning cardiac venous blood from the open atrium 
and the blood aspirated from the left intraventricular catheter were directed into a collecting 
chamber. Because a certain amount of air was always mixed with the blood returning from the 
atrium, the bubbles were dissipated during their gradual descent on the inner surfa(:e of the tall 
\ 
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cylinder. The negative pressure within the collecting chamber also assisted in dispersing 
bubbles. As the blood accumulated in a pool at the bottom of the collecting chamber, the 
elevation of the blood level was then sensed by the same variable capacitor used in the control of 
the arterial pump. This circuit energized an additional pump that returned both the cardiac 
venous and the left ventricular blood and bubbles to the extracorporeal circuit. 
A number of atrial septal defects were produced in dogs during total bypass and repaired by 
suturing a pericardial patch to the edge of the defect. In some situations, the patch was 
introduced into the right atrium through a stab wound onto the medial surface of the atrium and 
left connected to its base with the aim of providing circulatory support to the graft. This 
procedure was found to be unnecessary. In another group of animals, intraventricular septal 
defects were produced under direct vision by the use of a sharp cork borer and suction. These 
defect<:; were also 'repaired by direct suture of a pericardial patch. Ninety percent of these 
animals survived. 
Because the venous pumps were situated at a slightly higher level than the heart, a moderate 
degree of suction by the venous pumps was needed to ensure a maximal flow from the venae 
cavae. To further minimize the problem ofpulsatile blood flow from the DeBakeypumps, 
further modification of this circuit was necessary. Using mild negative pressure, caval blood was 
directed into a separate collecting chamber placed at a level below the heart. As the blood 
accumulated in the bottom of the chamber, the level was sensed by the same variable capacity 
electronic circuit used to automatically control the arterial pump. This system worked very well, 
and the pumping pulsation were effectively minimized. Four recording potentiometers were 
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included in the front panel of the machine as a means of providing permanent records of 
physiologic data. The pH record.er indicated the pH of arterialized blood and, in addition, 
maintained a pH of 7.2 by automatically adding carbon dioxide to the oxygenator when the pH 
rose above the normal value. Another recorder indicated the degree of oxygen saturation of rhe 
arterialized blood from a cuvette located in the arterial line measuring light transmission at both 
540 and 620 A. Another recorder indicated subject temperature and also controlled the 
temperature of the blood in the machine. There was excessive hemolysis of the blood in the 
machine because the heat required to elevate the temperature of the blood required a very high 
temperature gradient of the small sized blood heater elements. Consequently, the use of this 
feature was discontinued. The remaining recorder measured flow rate by means of a square 
wave flow meter but never functioned satisfactorily. 
Because cyclopropane and ether were anesthetics frequently used at that time, the machine was 
pressurized with nitrogen because of the possibility that sparks originating in the D.C. motor of 
the artery pump made explosion a real possibility. There was also, in addition, a battery operated 
emergency electrical supply in the event of failure of the hospital's electrical s•1pply. 
Under these conditions, the automatic controls would no longer function because of the energy 
requirement and the pumps would need to be controlled manually. Alternating 110 volts was 
made available by a bank of batteries operating a motor generator converter. 
Under normal operating conditions, all that was needed to initiate bypass and perfusion was the 
removal of the hemostats obstructing the venous and the arterial lines from the patient and to the 
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machine. As blood from the subject entered the extracorporeal circuit, the heart/lung machine 
then functioned completely automatically requiring only occasional adjustments of the negative 
pressure to the venous collecting chamber or small additions of blood as needed to maintain 
blood pressure. A large and successful experimental experience had been achieved by this time. 
The apparatus functioned splendidly. Oxygenation with a new oxygenator of greater capacity 
than the original one appeared to be sufficient for perfusion of a human patient of average size. 
Dr. Gibbon and this author, together with the laboratory group, had every confidence that the 
next phase, the use of the apparatus in operations upon humans, would also be successful. 
Accordingly, Dr. Gibbon initiated the use of this device in hum.an applications. 
In preparation for the first operation on a human patient, Gibbon practiced the procedure on one 
dog. The heart/lung machine was sterilized prior to use by first filling the machine with zephiran 
solution the evening before the contemplated operation, followed by repeated flushes with saline 
prior to filling of the machine with three units of blood. The first patients were two small 
children who failed to survive for reasons other than failure of perfusion. Interestingly, Dr. 
Gibbon suggested the use of the laboratory positive/negative pressure respirator in the second 
case because the anesthesia in the first child had been completely unsatisfactory. In May of 
1953, Dr. Gibbon successfully performed an open cardiotomy during bypass under direct vision 
at Jefferson and repaired an interatrial septal defect in a teenage girl. Unfortunately, because of 
the prolonged duration of the bilateral anterior thoracotomy and a marginal dose of heparin to the 
patient, blood clotting on the oxygenator screens took place during the closure of the defect. 
Automatic controls in the heart/lung machine sensed the problem instantaneously stopping all 
pumps. It was then necessary to make an emergency reconnection of the blood circuit and, while 
21 
I operated the pumps under manual control, maintain the patient's blood volume with fluids and 
what blood was available at the time. At this point, ventricular fibrillation occurred, but a 
normal rhythm was established immediately with an electric shock. This patient had an 
uncomplicated postoperative course, recovered completely, and has remained well with normal 
cardiac function for many years postoperatively. 
Unfortunately, at this point in time, an incident occurred that altered the direction and course of 
my career. My work had come to the attention of the Junior Chamber of Commerce, a national 
organization, who elected to present me with an award as 1 of the 10 Outstanding Young Men 
under the age of 35 of the Year. I had informed Dr. Gibbon first to obtain his permission to 
accept the award, which he gave. I had requested from the Junior Chamber of Commerce that 
any press release be first submitted to me and be approved prior to publication. I was aware of 
the very tender nature of Dr. Gibbon's feelings and of my own and was concemed·only that t~e 
statement be honest. However, in the citation that was to accompany the award, and was not 
shown to me for approval, described me as the co-inventor of the heart/lung machine. Nothi~g 
could be more trawnatic. This information released to the press did not reach Dr. Gibbon or me 
until the day or so before the presentation was to be made. I had, when I first became aware of 
the award, refused to accept the award. I made this known to Dr. Gibbon. After Dr. Gibbon 
reconsidered the entire matter, he then directed me in a three way phone call to receive the 
award, which I refused to do. I completely declined the award. Because of unpleasant feelings 
that evolved at this time, within a few months, I found associations with Dr. Gibbons to have 
deteriorated to the point at which I resigned. 
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Within a few days, the word of my resignation as Gibbons' research associate reached Dr. 
George Bennett, the Dean and also the Chainnan of the Department of Anatomy at Thomas 
Jefferson University. He had been aware of my performance as a student from my freshman 
days. He invited me to become a member of his staff in the Department of Anatomy at 
Jefferson, provided for a new laboratory, which he had constructed for me, complete with basic 
apparatus, with a stipend and also the use of his personal technician. Because of the many 
scientific questions that are always with me, there were a number of problems that I began to 
investigate. Funds were provided from the National Institute of Health, Tobacco Commission, 
and private sources for me for the development of an extracorporeal device to be use as a means 
of perfusing extremities containing tumors with chemotherapeutic agents, serum proteins, etc. in 
cancer patients, and a number of other topics for many many years. I continued research in 
many areas and published many papers from this laboratory. 
Frank Allbritton's motives were obvious and his conduct far from the standard of scientific 
honesty. As a resident, I always considered him a very demanding rigid individual whose 
vocabulary lacked completely the word ''Thank you.,. These feelings were shared by the surgical 
residents. 
In conclusion, as I look back, I thoroughly enjoyed my early association with Gibbon when I. was 
his resident and research associate. At one point, when all the problems with the heartnung 
machine were solved and septa! defects were produced and repaired during bypass with survival, 
Dr. Gibbon called me into his office one day and said, "BJ, you've done all of this work and you 
should be co-investigator on the grant." I had never expected such a response and was 
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astounded. The following day, he called me back to his office and said, "BJ, I thought it over 
and I'm going to wait a while." At that point, I could see the influence of Allbritton and Maley 
Gibbon lurking in the background. At Gibbon's request, I included Maley as one of the authors 
and Allbritton as the other in a number of papers despite the fact that neither had made any 
contribution in the four years during which time I directed the work. Finally, as time passed, 
Gibbon excluded me from the clinical aspects of the work. A number of years later, Gibbon sent 
me a letter indicating that he was removing my hospital and academic privileges. I was told by a 
number of the staff that the Executive Committee unanimously rejected his effort to do so. I 
continued to admit patients to Jefferson and operate upon them and also continued teaching my 
special courses in anatomy, which I had been doing for 45 years. In addition, the Alwnni 
Association at Jefferson recently presented me with the Alumni Achievement Award and also 
the Samuel D. Gross Award from the Department of Surgery. Unfortunately, my introduction to 
Gibbon was unpleasant and my departure from his service even more unpleasant. 
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